The Trump administration allocated $500 million to a universal vaccine initiative, a significant sum amidst budget cuts affecting other health research.
This investment contrasts with the administration's focus on next-generation Covid-19 vaccines.
The project is spearheaded by two scientists recently appointed to high-ranking positions at the National Institutes of Health (NIH).
This funding decision raises questions about priorities in healthcare investment given the simultaneous budget reductions and grant terminations within health agencies.